RxDoctor Payments Data

Elen Tylkin, MD

Psychiatry · Libertyville, ILNPI 1043306111

Payments from drug & device makers

$4,393in general payments, 2019–2025

Across 266 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$776
  • Lundbeck LLC$748
  • Otsuka America Pharmaceutical, Inc.$692
  • Alkermes, Inc.$612
  • Takeda Pharmaceuticals U.S.A., Inc.$429
  • Johnson & Johnson$207
  • plus $928 from 16 others

What the payments were for

  • Food & beverage$4,35599%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,393 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$109,512
Medicare patients
212
Services billed
1,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole45$104,615
VraylarCariprazine Hcl26$48,867
BelsomraSuvorexant67$39,766
UbrelvyUbrogepant11$31,950
OzempicSemaglutide19$26,756
Aripiprazole67$16,734
DayvigoLemborexant27$9,429
NeurontinGabapentin12$6,229
Lisdexamfetamine Dimesylate23$5,707
Ziprasidone Hcl19$5,440
Quetiapine Fumarate186$5,323
VyvanseLisdexamfetamine Dimesylate12$4,699
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl53$4,321
Bupropion XlBupropion Hcl150$4,238
ZubsolvBuprenorphine Hcl/Naloxone Hcl13$3,892

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$692$104,61545 claims
AbbVieVraylar, Ubrelvy$776$80,81737 claims
Eisai Inc.Dayvigo$12$9,42927 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$429$4,69912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Libertyville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →